Cargando…

Mental health, serum biomarkers and survival in severe COPD: a pilot study

BACKGROUND: Chronic obstructive pulmonary disease (COPD) impairs physical status and impacts on mental health. This prospective study was designed to assess associations between mental health and systemic biomarkers, and their combined relationship with long-term survival in stable severe COPD. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilz, Christian, Blaas, Stefan H., Pfeifer, Michael, Jörres, Rudolf A., Budweiser, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717533/ https://www.ncbi.nlm.nih.gov/pubmed/26788321 http://dx.doi.org/10.1186/s40248-016-0041-8

Ejemplares similares

Treatment of respiratory failure in COPD
por: Budweiser, Stephan, et al.
Publicado: (2008)

Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis
por: Budweiser, Stephan, et al.
Publicado: (2007)

Lung function and associations with multiple dimensions of dental health: a prospective observational cross-sectional study
por: Henke, Christian, et al.
Publicado: (2016)

Associations of Post-Acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave
por: Staudt, Anna, et al.
Publicado: (2022)

Patients’ treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections
por: Budweiser, Stephan, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

A simple risk score for mortality including the PCR Ct value upon admission in patients hospitalized due to COVID-19
por: Kurzeder, Luis, et al.
Publicado: (2022)

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Influence of body mass on predicted values of static hyperinflation in COPD
por: Alter, Peter, et al.
Publicado: (2018)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
por: Karl, Florian M., et al.
Publicado: (2017)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Bauchlage auch bei nicht intubierten Patienten mit Lungenversagen sinnvoll?
por: Budweiser, Stephan
Publicado: (2020)

Ältere Männer mit Hypertonie werden bei COVID-19 besonders oft intensivpflichtig
por: Budweiser, Stephan
Publicado: (2020)

Systemische Steroide als vorläufiger Therapiestandard bei schwerer COVID-19
por: Budweiser, Stephan
Publicado: (2020)

Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19
por: Budweiser, Stephan
Publicado: (2021)

Nasale High-Flow-Therapie statt früher Intubation hat auch bei COVID-19 Vorteile
por: Budweiser, Stephan
Publicado: (2021)

Ist Beatmung über Helm besser als nasale High-Flow-Therapie?
por: Budweiser, Stephan
Publicado: (2021)

Bauchlage des wachen Patienten senkt Intubationsrate und Mortalität
por: Budweiser, Stephan
Publicado: (2021)

Bauchlage bei wachen COVID-19-Patienten neuer Standard
por: Budweiser, Stephan
Publicado: (2021)

Bauchlage senkt Intubationsrate bei wachen COVID-19-Patienten auf Intensivstation
por: Budweiser, Stephan
Publicado: (2022)

Hohe Symptomlast noch ein Jahr nach Intensivtherapie wegen COVID-19
por: Budweiser, Stephan
Publicado: (2022)

Sterblichkeit bei schwerer COVID-19 mit invasiver Beatmung bei Älteren eher über 50 %!
por: Budweiser, Stephan
Publicado: (2021)

Bauchlage am wachen Patienten: Ja, aber…
por: Budweiser, Stephan
Publicado: (2022)

Nasale High Flow Therapie als neue Therapieoption!?
por: Budweiser, Stephan
Publicado: (2022)

Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction
por: Hofer, Stefan, et al.
Publicado: (2009)

Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients
por: Keller, Andreas, et al.
Publicado: (2019)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study
por: Jung, Anna Lena, et al.
Publicado: (2023)

Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD
por: Bräunlich, Jens, et al.
Publicado: (2019)

Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality
por: Kahnert, Kathrin, et al.
Publicado: (2023)

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019)

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD
por: Alter, Peter, et al.
Publicado: (2019)

Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Capnovolumetry in combination with clinical history for the diagnosis of asthma and COPD
por: Kellerer, C., et al.
Publicado: (2020)

Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD
por: Pinto-Plata, Victor, et al.
Publicado: (2012)

Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers
por: Chen, Qiuying, et al.
Publicado: (2015)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c90gmqe3u5u1mu24o0n06rq7su